Pulmonary Fibrosis News Home | Pulmonary Fibrosis News
WEBNeed to know. Becoming educated and informed about PF is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes. Get informed.
New prototype therapy may repair IPF lung scarring by …
WEBApr 26, 2024 · Researchers have developed an inhalable prototype medicine that may be able to repair lung scarring caused by idiopathic pulmonary fibrosis (IPF) by stimulating the growth of stem cells directly in the lungs, a study reports.
Study reveals potential to reverse lung fibrosis using the body's …
WEBApr 12, 2024 · Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis (IPF) and related lung conditions, which can cause worsening shortness of breath, dry cough, and...
BMS-986278 declared breakthrough therapy for progressive PF
WEBOct 27, 2023 · The FDA’s decision to grant breakthrough therapy designation to BMS-986278 was based on results from a global Phase 2 clinical trial (NCT04308681) assessing the safety and efficacy of BMS-986278 in 278 people with …
New study offers hope for pulmonary fibrosis patients - Medical Xpress
WEBSep 30, 2023 · Using a new recipe for growing blood vessels from living lung tissue in the lab, a University of Virginia School of Engineering and Applied Science research team has developed an analytical tool...
Experimental anticancer drug shows promise as treatment for Idiopathic …
WEBAug 23, 2022 · An experimental anticancer drug called saracatinib shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), a chronic and often fatal condition that causes scarring or fibrosis of the lungs and makes breathing difficult.
Boehringer Aces Phase III Pulmonary Fibrosis Trial, Plans FDA ...
WEB4 days ago · Boehringer Ingelheim will use the findings from FIBRONEER-IPF to support a drug application for nerandomilast with the FDA and other regulatory authorities worldwide. The company expects to present full data and analyses from FIBRONEER-IPF in the first half of 2025. Idiopathic pulmonary fibrosis (IPF) “has a high unmet need for patients ...
Nerandomilast Shows Promise in Idiopathic Pulmonary Fibrosis …
WEB5 days ago · IPF is a rare progressive fibrosing interstitial lung disease with symptoms that include breathing difficulty, dry and persistent cough, chest discomfort and fatigue. The randomized, double-blind ...
Researchers identify new molecular target for idiopathic pulmonary ...
WEBMar 10, 2021 · Researchers have identified a new molecular target that could lead to new treatments for idiopathic pulmonary fibrosis (IPF), a deadly lung disease. IPF is characterized by severe scarring of the lungs, a condition called fibrosis, which makes it progressively difficult to breathe.
PRECISIONS Study for Idiopathic PF | Pulmonary Fibrosis …
WEBJan 11, 2021 · This is the first clinical trial to apply the principles of precision medicine to the treatment of patients with idiopathic pulmonary fibrosis (IPF). The trial aims to determine if N-Acetyl-cysteine (NAC) is an effective treatment in a subset of IPF patients who carry a particular genetic variant.